Sachs Bruce I's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Jul 18, 2023
- Accession no.
- 0001209191-23-042566
- Filed
- Jul 18, 2023
- Trade date
- Jul 14-17, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.01M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sachs Bruce ICIK 0001197036 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2023 | Common Stock | MOption exerciseAcquired | +11,250 | $127.54 | +$1,434,825 | 51,250 | Direct | |
| Jul 17, 2023 | Common Stock | SSaleDisposed | −1,697 | $355.54F2,F3 | −$603,351.38 | 49,553 | Direct | |
| Jul 17, 2023 | Common Stock | SSaleDisposed | −5,711 | $356.75F2,F4 | −$2,037,399.25 | 43,842 | Direct | |
| Jul 17, 2023 | Common Stock | SSaleDisposed | −3,842 | $357.29F2,F5 | −$1,372,708.18 | 40,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2023 | Common Stock | AGrant or awardAcquired | +124.72 | $350.79 | +$43,750.53 | 14,524.97 | Direct | |
| Jul 17, 2023 | Common Stock | MOption exerciseDisposed | −11,250 | $0.00 | $0 | 11,250 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $355.54 (range $355.00 to $355.97).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $356.75 (range $356.00 to $356.99).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $357.29 (range $357.00 to $357.38).
Referenced by the price of 1 transaction in Table I.